Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Drug groups primarily affecting central nervous system adverse reaction (disorder) | est un(e) (attribut) | effet indésirable d'un médicament | false | Inferred relationship | Some | ||
| Drug groups primarily affecting central nervous system adverse reaction (disorder) | Causative agent | Central nervous system agent (substance) | false | Inferred relationship | Some | 1 | |
| Drug groups primarily affecting central nervous system adverse reaction (disorder) | Causative agent | produit pharmaceutique ou biologique | false | Inferred relationship | Some | ||
| Drug groups primarily affecting central nervous system adverse reaction (disorder) | Causative agent | produit pharmaceutique ou biologique | false | Inferred relationship | Some | ||
| Drug groups primarily affecting central nervous system adverse reaction (disorder) | Causative agent | Central nervous system agent (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Moracizine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Centrally acting appetite suppressant adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Dopaminergic drug used in parkinsonism adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Antidepressant drug adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Antiepileptic adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Sedative/neuroleptic adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Decarboxylase inhibitor adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Central stimulant adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Alcohol metabolism modifier adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Serotonin syndrome (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Anesthetics and medical gases adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction caused by hallucinogen (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Drug reaction to anticonvulsant (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to antiparkinsonism drugs NOS (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to anticonvulsant and antiparkinsonism drugs NOS (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to other psychotropic agent (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to psychotropic agent NOS (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Drug reaction - CNS drug NOS (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Tetrabenazine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| [X]Benzodiazepines causing adverse effects in therapeutic use (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| [X]Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Opioid analgesic adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Physostigmine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Edrophonium adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Pyridostigmine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Neostigmine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Hyoscine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Trihexyphenidyl adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Benztropine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Procyclidine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Diphenhydramine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Hydroxyzine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Cabergoline adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Quinagolide adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Dihydroergocornine and dihydroergocristine and dihydroergocryptine adverse reaction (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Dihydroergotamine mesylate adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction caused by central nervous system muscle-tone depressants (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction caused by theobromine (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to central nervous system muscle-tone depressants NOS (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to central nervous system depressants and anesthetics NOS (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Cocaine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction caused by pyrabital (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Nabilone adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Trichloroethylene adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Nicotine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Thiethylperazine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to antiparkinsonism drug | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to barbiturate | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to hypnotic AND/OR sedative | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Alimemazine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Thioridazine retinopathy | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Adverse reaction to other central nervous system depressants and anesthetics (disorder) | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Neuroleptic adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Retinopathy caused by trifluoperazine | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Pholcodine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Pentazocine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Phenazocine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Methadone analog adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Buprenorphine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Codeine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Diamorphine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Dihydrocodeine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Morphine adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Pethidine analog adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some | |
| Meptazinol adverse reaction | est un(e) (attribut) | False | Drug groups primarily affecting central nervous system adverse reaction (disorder) | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR